APRE

APREA THERAPEUTICS INC

APRE·03836J201·US·Common Stock·Healthcare - Biotechnology-13D/G

APRE (APREA THERAPEUTICS INC) is held by 13 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($90,890), BNP PARIBAS FINANCIAL MARKETS ($30,376), VANGUARD FIDUCIARY TRUST CO ($29,348). Net institutional sentiment: Mixed.

13
Holders
Avg rating(4 Elite)
$247,135
Total Value
43% (17)
Fund Consensus
6 buying - 8 selling
APRESmart Money Verdict
View all
Held by 13 funds
4 elite
Who's Trading
ActivistVPVestal Point Capital, LP9.9%May 15, 2026
ActivistOHOrin Hirschman9.9%Apr 27, 2026
ActivistSMSquadron Master Fund LP9.9%Apr 7, 2026
ActivistSPSoleus Private Equity Fund III, L.P.10.0%Apr 1, 2026
ActivistNANantahala Capital Management, LLC4.5%Feb 13, 2026
InsiderDMDuey MarcBuy $25KDec 10, 2025
InsiderHPHamill John P.Buy $6KDec 10, 2025
ActivistLLLYTTON LAURENCE W9.9%Nov 17, 2025
InsiderGOGilad OrenBuy $4KApr 3, 2025
InsiderGOGilad OrenBuy $6KApr 3, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
119,131(+190.9%)$90,8900.0%-57.69%
24
Increased
39,817(+45.7%)$30,3760.0%-58.45%
18
New
38,464$29,3480.0%-11.76%
30
New
25,100$19,1490.0%-11.76%
28
Decreased
22,330(-71.0%)$17,0360.0%-69.86%
0
Decreased
21,052(-19.2%)$16,0610.0%-69.01%
0
New
19,622$14,9720.0%-11.76%
28
Unchanged
13,864$10,5770.0%-88.79%
0
New
13,018$9,9310.0%-11.76%
26
Unchanged
8,504$6,4870.0%-78.45%
0
Decreased
2,153(-12.5%)$1,6430.0%-15.90%
0
Unchanged
577$4400.0%-98.95%
0
Decreased
295(-1.7%)$2250.0%-82.63%
0
Exited
0(-100.0%)$20,7310.0%-4.49%
0
Exited
0(-100.0%)$43,5380.0%-4.49%
0
Exited
0(-100.0%)$39,7670.0%-4.49%
0
Exited
0(-100.0%)$2,8140.0%-75.55%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used